Modernizing regulation of diagnostic tests is essential to improve patient care and support innovation.
AdvaMedDx has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
AdvaMed: VALID Act an “Important Step Toward the Long-Overdue Modernization” of Law Governing Diagnostic Tests
AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
Advancing Diagnostics Together: In-Person & Virtual offerings with complete coverage of the most timely and important issues for the diagnostics industry.
The VALID Act marks a milestone in AdvaMedDx efforts to secure a diagnostic-specific, risk-based and modernized for innovation, regulation of all diagnostic tests – LDTs and IVDs.
AdvaMedDx supports the modernization of the regulatory framework for all clinical diagnostic tests to foster innovation, embrace scientific advances, and ensure swift access to accurate and reliable tests for all…
AdvaMedDx members represent the world’s leading diagnostics manufacturers alongside the next generation of companies developing innovative diagnostic tests and technologies in the U.S. and abroad.
AdvaMedDx members are medical technology firms that manufacture an in vitro diagnostic device or engage in research and development of such diagnostics.
AdvaMedDx collaborates with diagnostics associations across the country and around the world.
AdvaMedDx promotes innovation and expanded access to quality testing.